Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

May 01, 2002; Volume 30,Issue 5

Short Communications

  • You have access
    Effects of a P-Glycoprotein Inhibitor on Brain and Plasma Concentrations of Anti-Human Immunodeficiency Virus Drugs Administered in Combination in Rats
    Jouko Savolainen, Jeffrey E. Edwards, Michael E. Morgan, Patrick J. McNamara and Bradley D. Anderson
    Drug Metabolism and Disposition May 2002, 30 (5) 479-482; DOI: https://doi.org/10.1124/dmd.30.5.479
  • You have access
    Identification of the Cytochromes P450 That Catalyze Coumarin 3,4-Epoxidation and 3-Hydroxylation
    Stephanie L. Born, Douglas Caudill, Kristine L. Fliter and Michael P. Purdon
    Drug Metabolism and Disposition May 2002, 30 (5) 483-487; DOI: https://doi.org/10.1124/dmd.30.5.483

Symposium Article

  • You have access
    Current Progress on Esterases: From Molecular Structure to Function
    Tetsuo Satoh, Palmer Taylor, William F. Bosron, Sonal P. Sanghani, Masakiyo Hosokawa and Bert N. La Du
    Drug Metabolism and Disposition May 2002, 30 (5) 488-493; DOI: https://doi.org/10.1124/dmd.30.5.488

Articles

  • You have access
    Structure-Activity Relationship inO-Glucuronidation of Indolocarbazole Analogs
    Norihiro Takenaga, Mikio Ishii, Toshio Kamei and Toshio Yasumori
    Drug Metabolism and Disposition May 2002, 30 (5) 494-497; DOI: https://doi.org/10.1124/dmd.30.5.494
  • You have access
    Carrier-Mediated Active Transport of a Novel Thromboxane A2 Receptor Antagonist [2-(4-Chlorophenylsulfonylaminomethyl)indan-5-yl]acetate (Z-335) into Rat Liver
    Yoshihiro Kawabata, Shigeru Furuta, Yutaka Shinozaki, Tadashi Kurimoto and Ryuichiro Nishigaki
    Drug Metabolism and Disposition May 2002, 30 (5) 498-504; DOI: https://doi.org/10.1124/dmd.30.5.498
  • You have access
    Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization
    Thomayant Prueksaritanont, Raju Subramanian, Xiaojun Fang, Bennett Ma, Yue Qiu, Jiunn H. Lin, Paul G. Pearson and Thomas A. Baillie
    Drug Metabolism and Disposition May 2002, 30 (5) 505-512; DOI: https://doi.org/10.1124/dmd.30.5.505
  • You have access
    Neotrofin Is Transported Out of Brain by a Saturable Mechanism: Possible Involvement of Multidrug Resistance and Monocarboxylic Acid Transporters
    Rongzi Yan and Eve M. Taylor
    Drug Metabolism and Disposition May 2002, 30 (5) 513-518; DOI: https://doi.org/10.1124/dmd.30.5.513
  • You have access
    3-O-Methyldobutamine, a Major Metabolite of Dobutamine in Humans
    Maohe Yan, Leslie T. Webster and Jeffrey L. Blumer
    Drug Metabolism and Disposition May 2002, 30 (5) 519-524; DOI: https://doi.org/10.1124/dmd.30.5.519
  • You have access
    Triethylenethiophosphoramide Is a Specific Inhibitor of Cytochrome P450 2B6: Implications for Cyclophosphamide Metabolism
    James M. Rae, Nadia V. Soukhova, David A. Flockhart and Zeruesenay Desta
    Drug Metabolism and Disposition May 2002, 30 (5) 525-530; DOI: https://doi.org/10.1124/dmd.30.5.525
  • You have access
    Glucuronidation of the Dietary Fatty Acids, Phytanic Acid and Docosahexaenoic Acid, by Human UDP-Glucuronosyltransferases
    Joanna M. Little, Lisa Williams, Jing Xu and Anna Radominska-Pandya
    Drug Metabolism and Disposition May 2002, 30 (5) 531-533; DOI: https://doi.org/10.1124/dmd.30.5.531
  • You have access
    Effects of Endogenous Steroids on CYP3A4-Mediated Drug Metabolism by Human Liver Microsomes
    Hiroyoshi Nakamura, Hiromitsu Nakasa, Itsuko Ishii, Noritaka Ariyoshi, Takashi Igarashi, Shigeru Ohmori and Mitsukazu Kitada
    Drug Metabolism and Disposition May 2002, 30 (5) 534-540; DOI: https://doi.org/10.1124/dmd.30.5.534
  • You have access
    Human and Rodent Carboxylesterases: Immunorelatedness, Overlapping Substrate Specificity, Differential Sensitivity to Serine Enzyme Inhibitors, and Tumor-Related Expression
    Mingxing Xie, Dongfang Yang, Lan Liu, Bob Xue and Bingfang Yan
    Drug Metabolism and Disposition May 2002, 30 (5) 541-547; DOI: https://doi.org/10.1124/dmd.30.5.541
  • You have access
    Expression of the Rat CYP2A3 Gene in Transgenic Mice
    Ting Su, Qing-Yu Zhang, Jianhua Zhang, Pam Swiatek and Xinxin Ding
    Drug Metabolism and Disposition May 2002, 30 (5) 548-552; DOI: https://doi.org/10.1124/dmd.30.5.548
  • You have access
    The Metabolism and Excretion of Galantamine in Rats, Dogs, and Humans
    G. S. J. Mannens, C. A. W. Snel, J. Hendrickx, T. Verhaeghe, L. Le Jeune, W. Bode, L. van Beijsterveldt, K. Lavrijsen, J. Leempoels, N. Van Osselaer, A. Van Peer and W. Meuldermans
    Drug Metabolism and Disposition May 2002, 30 (5) 553-563; DOI: https://doi.org/10.1124/dmd.30.5.553
  • You have access
    Induction of Human UDP-Glucuronosyltransferase UGT1A1 by Flavonoids—Structural Requirements
    U. Kristina Walle and Thomas Walle
    Drug Metabolism and Disposition May 2002, 30 (5) 564-569; DOI: https://doi.org/10.1124/dmd.30.5.564
  • You have access
    Induction of CYP3A Expression by Dehydroepiandrosterone: Involvement of the Pregnane X Receptor
    Sharon L. Ripp, Jennifer L. Fitzpatrick, Jeffrey M. Peters and Russell A. Prough
    Drug Metabolism and Disposition May 2002, 30 (5) 570-575; DOI: https://doi.org/10.1124/dmd.30.5.570
  • You have access
    Glucuronidation versus Oxidation of the Flavonoid Galangin by Human Liver Microsomes and Hepatocytes
    Yoko Otake, Faye Hsieh and Thomas Walle
    Drug Metabolism and Disposition May 2002, 30 (5) 576-581; DOI: https://doi.org/10.1124/dmd.30.5.576
  • You have access
    Sulfation of Budesonide by Human Cytosolic Sulfotransferase, Dehydroepiandrosterone-Sulfotransferase (DHEA-ST)
    Connie A. Meloche, Vyas Sharma, Stellan Swedmark, Paul Andersson and Charles N. Falany
    Drug Metabolism and Disposition May 2002, 30 (5) 582-585; DOI: https://doi.org/10.1124/dmd.30.5.582
  • You have access
    Intestinal Metabolism: The Role of Enzyme Localization in Phenol Metabolite Kinetics
    Prajakti A. Kothare and Cheryl L. Zimmerman
    Drug Metabolism and Disposition May 2002, 30 (5) 586-594; DOI: https://doi.org/10.1124/dmd.30.5.586
  • You have access
    Characterization of Cytochrome P450 2D6.1 (CYP2D6.1), CYP2D6.2, and CYP2D6.17 Activities toward Model CYP2D6 Substrates Dextromethorphan, Bufuralol, and Debrisoquine
    Kenda A. Marcucci, Robin E. Pearce, Charles Crespi, Dorothy T. Steimel, J. Steven Leeder and Andrea Gaedigk
    Drug Metabolism and Disposition May 2002, 30 (5) 595-601; DOI: https://doi.org/10.1124/dmd.30.5.595
  • You have access
    Metabolism of (+)- and (−)-Limonenes to Respective Carveols and Perillyl Alcohols by CYP2C9 and CYP2C19 in Human Liver Microsomes
    Mitsuo Miyazawa, Masaki Shindo and Tsutomu Shimada
    Drug Metabolism and Disposition May 2002, 30 (5) 602-607; DOI: https://doi.org/10.1124/dmd.30.5.602

Accelerated Communication

  • You have access
    Induction of Cytochrome P450 3A4 in Primary Human Hepatocytes and Activation of the Human Pregnane X Receptor by Tamoxifen and 4-Hydroxytamoxifen
    Pankaj B. Desai, Srikanth C. Nallani, Rucha S. Sane, Linda B. Moore, Bryan J. Goodwin, Donna J. Buckley and Arthur R. Buckley
    Drug Metabolism and Disposition May 2002, 30 (5) 608-612; DOI: https://doi.org/10.1124/dmd.30.5.608
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 30 (5)
Drug Metabolism and Disposition
Vol. 30, Issue 5
1 May 2002
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Short Communications
  • Symposium Article
  • Articles
  • Accelerated Communication
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics